Skip to main content
. 2020 Aug 29;156:133–187. doi: 10.1016/j.addr.2020.08.008

Fig. 27.

Fig. 27

PASylation of therapeutics for improved pharmacokinetic properties. (A) Pharmacokinetic profile of recombinant and PASylated IFN in BALB/c mice. The number within the parentheses in the PASylated versions indicates the length of the PAS peptide. (B) Pharmacokinetic profile of recombinant and PASylated hGH injected intravenously or subcutaneously. Adapted from [426].